[ad_1]
The US Division of Justice (DOJ) has launched an antitrust probe into UnitedHealth Group, scrutinising the medical health insurance big’s growth and acquisitions, reported Bloomberg, citing sources.
The probe focuses on the US firm’s rising affect throughout numerous healthcare sectors together with pharmacy advantages, medical care and know-how companies.
Considerations have been raised relating to UnitedHealth’s acquisitions of healthcare suppliers and knowledge corporations.
The corporate, recognized for its UnitedHealthcare insurance coverage unit that covers greater than 47 million People, has declined to touch upon the investigation, and so has the Justice Division.
UnitedHealth’s progress has been pushed by its Optum arm, which incorporates clinics, house care companies, drug plans and pharmacies.
These companies typically cater to UnitedHealthcare members, changing insurance coverage enterprise bills into income for Optum.
Entry probably the most complete Firm Profiles
available on the market, powered by GlobalData. Save hours of analysis. Achieve aggressive edge.
Firm Profile – free
pattern
Thanks!
Your obtain electronic mail will arrive shortly
We’re assured in regards to the
distinctive
high quality of our Firm Profiles. Nonetheless, we wish you to take advantage of
useful
determination for your enterprise, so we provide a free pattern you could obtain by
submitting the beneath type
By GlobalData
Though profitable for UnitedHealth, this technique has attracted scrutiny from antitrust regulators.
The DOJ can be reviewing UnitedHealth’s deliberate $3.3bn buy of house well being supplier Amedisys, following final 12 months’s acquisition of rival LHC Group.
In 2022, the division unsuccessfully sued to dam UnitedHealth’s acquisition of Change Healthcare, a significant digital knowledge clearinghouse.
UnitedHealth executives keep that there’s a strict separation between the insurance coverage enterprise and Optum companies.
They spotlight that Optum additionally gives companies to numerous insurance coverage corporations that compete with UnitedHealthcare.
UnitedHealth is at present beneath investigation, audit or assessment by greater than a dozen US authorities, together with the DOJ, as disclosed within the firm’s regulatory filings.
In December 2023, UnitedHealth agreed to promote its Brazilian medical health insurance enterprise, Amil, to businessman Jose Seripieri Filho in a transaction valued at roughly $2.24bn.
[ad_2]